Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1645 studies found for:    "Hepatitis, Chronic"
Show Display Options
Rank Status Study
21 Recruiting A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)
Conditions: Healthy;   Hepatitis, Chronic
Interventions: Drug: JNJ-56136379;   Drug: Placebo
22 Enrolling by invitation Efficacy of Medical Ozone Therapy in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Device: medical ozone therapy with tianyi;   Device: medical ozone therapy with humares;   Drug: Diammonium glycyrrhizinate Capsules
23 Recruiting PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: Peginterferon alfa-2a;   Drug: Nucleos(t)ide analogue
24 Completed 4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Nitazoxanide;   Biological: Peginterferon alfa-2a
25 Withdrawn Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Intervention: Drug: Prednisone Priming
26 Completed Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients
Condition: Chronic Hepatitis C
Intervention: Drug: Amantadine
27 Recruiting Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection
Condition: Chronic Hepatitis B
Interventions: Drug: Telbivudine;   Drug: Placebo
28 Completed Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)
Condition: Chronic Hepatitis B
Intervention: Drug: Lamivudine/ Placebo 100mg daily
29 Completed Study on Second Stage Follow-up of Therapeutic Hepatitis B Vaccine in Treating Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Intervention: Biological: εPA-44
30 Completed High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon alfa 2 A;   Drug: Peginterferon alfa 2 A, ribavirin + Epo Beta;   Drug: ribavirin;   Drug: Peginterferon alfa 2
31 Completed Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: Pegylated Interferon;   Drug: Lamivudine
32 Terminated Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: adefovir;   Drug: clevudine;   Drug: lamivudine
33 Unknown  Vitamin D as an add-on Therapy With Pegylated Interferon and Ribavirin for Chronic Hepatitis c
Condition: Chronic Hepatitis c
Interventions: Drug: vitamin D +pegylated interferon + ribavirin;   Drug: pegylated interferon + ribavirin
34 Completed Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Ypeginterferon alfa-2b;   Drug: Pegasys
35 Completed A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon
Condition: Chronic Hepatitis B
Intervention: Drug: pegylated Interferon-alpha 2a
36 Completed Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: LB80380
37 Completed A Phase 2 Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: VX-135;   Drug: ribavirin
38 Completed Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon alfa-2a + ribavirin in normal ALT;   Drug: Peginterferon alfa-2a + ribavirin in elevated ALT
39 Unknown  Therapeutic Hepatitis B Vaccine (Synthesized Peptide εPA-44) Joint Entecavir in Treating Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: Therapeutic HBV vaccine, entecavir;   Drug: Empty liposome, entecavir
40 Unknown  HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside Maintenance
Condition: Chronic Hepatitis B
Interventions: Drug: PEG-interferon-Alfa-2A;   Drug: Nucleosides

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.